-
2024-516266-11-00
5
2020-01-06
yeast intra-abdominal infection, peritonitis
-
2024-512321-84-00
5
2019-10-02
Patients after HSCT suffering from new or reactivated CMV or EBV or Ad
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2024-510580-28-00
5
2019-06-05
Middle or low locally advanced resectable rectal carcinoma
-
2024-512034-14-00
5
2019-03-04
severe trauma
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2024-515409-25-00
4
2018-01-11
Chronic myeloid leukemia
-
2023-504520-26-00
5
2017-10-19
Duchenne Muscular Dystrophy (DMD)
-
2023-508128-37-00
5
2017-07-19
All patients who have been treated with Novartis or Penn CAR T-cell th
-
2024-516103-16-00
4
2015-12-04
Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
-
2024-517390-24-00
5
2011-04-26
Ovarian epithelial cancer : intraperitoneal resectable relapse
-
2025-521302-17-00
10
2026-05-26
Hihg risk of cholangiocarcinoma intra hépatic resectable
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2024-517078-52-00
5
2026-01-19
Patients operated with an IPAA for ulcerative colitis woth active recu
-
2024-516873-57-00
10
2026-01-13
Acute myeloid leukemia in adults aged 18 to 60
-
2024-515438-33-00
5
2026-01-12
Alopecia areata
-
2025-520563-41-00
7
2025-09-29
High-grade glioma
Glioblastoma
-
2024-516473-72-00
5
2025-07-31
Multifocal Motor Neuropathy
-
2024-519575-26-00
4
2025-07-25
Chronic pulmonary aspergillosis (CPA)
-
2024-516811-25-00
4
2025-05-15
Parkinson Disease
-
2024-517169-18-00
5
2025-04-10
Multiple System Atrophy
-
2024-515741-42-00
5
2025-03-28
hereditary angioedema due to C1 esterase inhibitor deficiency (Type 1
-
2024-516247-62-00
5
2025-03-10
Hereditary Angioedema